Black Diamond Therapeutics, Inc.BDTXNASDAQ
Loading
EPS Growth AcceleratingAccelerating
Percentile Rank100
3Y CAGR+68.4%
Studio
Year-over-Year Change

Year-over-year earnings per share growth rate

3Y CAGR
+68.4%/yr
Annual compound
Percentile
P100
Near historical high
vs 3Y Ago
4.8x
Strong expansion
Streak
2 yr
Consecutive growthAccelerating
PeriodValue
2025130.71%
202432.45%
202325.40%
202227.38%
2021-70.10%
2020-77.39%
2019-79.69%
20180.00%
20170.00%